Vascular organoids restore microvessels in damaged heart tissue

Researchers have successfully reversed microvascular damage in the heart using vascular organoids—cellular aggregates capable of forming new blood vessels—transplanted as patches onto the cardiac surface. The approach combines endothelial progenitor cells isolated from human blood with bone marrow-derived smooth muscle cells, creating a structure that mimics the natural extracellular matrix and enhances transplanted cell survival. In studies with pigs suffering from ischemic heart disease, the patches not only significantly improved cardiac function compared to untreated animals but also halted progression toward heart failure over four weeks of monitoring. Particularly promising is that patch cells migrated into deeper layers of cardiac tissue, suggesting genuine integration rather than superficial deposition. This strategy opens perspectives beyond coronary pathology: capillary density loss is a universal hallmark of tissue aging, and restoring youthful microvascular networks could prove transformative for organs chronically starved of oxygen.